Panel discussion and audience "Q&A"

5 More presentations in this session

Welcome and introduction 

Professor A. Catapano (Milan, IT)

New guidelines: key changes with clinical impact

Professor F. Mach (Geneva, CH)

Preventing cardiovascular events through oral triple combination therapy

Professor K. Stach-Jablonski (Potsdam, DE)

1-year MILOS insights: real-world evidence confirming combination

Associate Professor T. Stulnig (Vienna, AT)

Closing remarks